Thierry Jean

Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA.

Agency for Science, Technology & Research engages in fostering scientific research and development. It is the agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. The company was founded in 1991 and is headquartered in Singapore.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award.

Ferring Research Institute, Inc. is a biopharmaceutical company, which engages in identifying, developing, and marketing of products. It focuses on the fields of endocrinology, gastroenterology, infertility, obstetrics, urology and osteoarthritis. The company is headquartered in San Diego, CA.

Institut des Hautes Etudes pour la Science et la Technologie (IHEST) offers seminars and interventions to elected officials and public officials to promote the use of science in decision-making. The company is based in Paris, France and ultimately controlled by the Government of France. The board of directors includes 19 members, including representatives from the government and former auditors. The IHEST brings in high-level speakers from various fields to provide training to executives on economic and societal issues using scientific knowledge and collective intelligence.

Diverchim SA provides pharmaceutical services. It offers computer aided drug, medicinal chemistry, immunochemistry, chemical development, analytical services, and discovery. The firm products are building blocks and screening, collection, and new tools for asymmetric catalysis. The company was founded by Jean Louis Brayer and Benoit Folleas in March 2001 and is headquartered in Roissy-en-France, France.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Pharma GmbH & Co., KG is a company that operates research-based pharmaceutical companies and serves. Boehringer Ingelheim Pharma GmbH & Co., KG is based in Ingelheim, Germany. The German company was founded in 1885 by Albert Boehringer. The CEO is Hubertus von Baumbach.

Société Financière de Communication et du Multimedia SAS provides interactive online services. The company was founded on July 17, 1989 and is headquartered in Saint Denis, France.

ConnectImmo NV operates as real estate company. It manages the commercial, financial, legal and technical aspects of the real estate portfolio. The company is headquartered in Brussels, Belgium.

Belgacom International Carrier Services SA provides telecommunication services. The firm offers voice, data, connectivity, messaging, roaming, business intelligence, analytics, and fraud and authentication solutions. The company was founded by Bridget Cosgrave in 1997 and is headquartered in Brussels, Belgium.

Part of Vivendi SE, Groupe Telindus France SA is a French company that provides telecommunication network services. The company is based in Les Ulis, France. Groupe Telindus France was acquired by Vivendi SE from Proximus SA on April 30, 2014 for $129.09 million.

Sorégies SA engages in the provision of electricity and gas generation, transmission and distribution services. It offers . The company was founded in 1925 and is headquartered in Poitiers, France.

Institut de Recherche pour le Développement operates as a scientific and technical public institution which provides information, expertise, support and training in production performance. It performs research centered on the relationship between human beings and its environment in intertropical areas. In that context the IRD implements research projects on sleeping sickness and the vectors transmitting the disease. The company is headquartered in Marseille, France.

ORPHELIA Pharma SA specializes on biopharmaceutical products improving the health and well being of severely disabled children. The company was founded by Hugues Bienaymé in 2007 and is headquartered in Paris, France.

Proximus Group Services SA is a private company based in Brussels, Belgium. The Belgian company's website, Proximus Group website, provides information about the Proximus Group.

Proximus Art VZW is a Belgian company founded in 1996 that provides digital services and communication solutions in both the Belgian and international markets. Additionally, information about shareholder remuneration can be found on their website. The company is based in Schaarbeek, Belgium. The company's website offers stock information and share prices for the stock market index BEL20 and major European/Telecom indexes. Proximus Art is ultimately controlled by the Government of Belgium.

Cennerv Pharmaceuticals Ltd. engages in the pharmaceutical development specializing in CNS disorders with an initial focus on mental health such as depression, insomnia, dementia, schizophrenia and autism. The company was founded on July 13, 2015 and is headquartered in Singapore.

Société de Chimie Thérapeutique is a French Medchem Society based in Malabry, France. The society is administered by an Executive Board and provides for the re-election or replacement of its members through a call for nominations process. The society also supports young researchers by providing a prestigious prize entitled “Prix d’Encouragement à la Recherche en Chimie Thérapeutique” sponsored by Institut de Recherche Servier, which is devoted to junior European scientists. The society complies with the law of July 10, 2012, on various provisions relating to electronic communications and transposes the European Directive No. 2009/136/EC of the European Parliament and of the Council of November 25, 2009, regarding the new constraints and obligations of publishers and owners of websites on information. The call for 2023 Young Medicinal Chemist in Industry Award is now closed, and the new call will be announced in November 2023.

Part of Mobilitas SA, AGS International Movers Tanzania Dar es Salaam is a company that provides moving services. The company is based in Dar es Salaam, Tanzania.

Part of Eurofins Scientific SE, Eurofins GSC France SAS is a French company that provides inspection, technical analysis, and test services. The company is based in Nantes, France.

Part of Eurofins Scientific SE, Eurofins GSC CADET SAS engages in analysis, testing and technical inspection. The company is based in Nantes, France.

Part of Eurofins Scientific SE, Eurofins ADME BIOANALYSES SAS is a contract research organization that provides diverse services to the pharmaceutical industry. The company is based in Vergeze, France.

Atamyo Therapeutics SAS is a clinical-stage biopharmaceutical company based in France. Atamyo leverages unique expertise in AAV-based gene therapy and muscular dystrophies from the Progressive Muscular Dystrophies Laboratory at Genethon, a spin-off of gene therapy pioneer Genethon. Atamyo's most advanced programs address different forms of limb-girdle muscular dystrophies (LGMD), with two clinical-stage programs targeting respectively LGMD-R9 and LGMD-R5. The name of the French company is derived from two words\: Celtic Atao which means "always" or "forever" and Myo which is the Greek root for muscle. Atamyo conveys the spirit of its commitment to improve the life of patients affected by neuromuscular diseases with life-long efficient treatments. Atamyo brings to patients with musculoskeletal diseases a new generation of gene therapies with enhanced safety and efficacy. The private company was founded in 2020 by Stéphane Degove and Isabelle Richard. Stéphane Degove has been the CEO since 2020.